MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 93 filers reported holding MEI PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $74,000 | +60.9% | 190,305 | +148.7% | 0.00% | – |
| Q2 2022 | $46,000 | -85.6% | 76,514 | -36.1% | 0.00% | -100.0% |
| Q4 2021 | $320,000 | -46.9% | 119,674 | -45.2% | 0.00% | -33.3% |
| Q3 2021 | $603,000 | -31.1% | 218,366 | -28.9% | 0.00% | -25.0% |
| Q2 2021 | $875,000 | -31.5% | 307,008 | -17.5% | 0.00% | -42.9% |
| Q1 2021 | $1,277,000 | +7.7% | 372,224 | -17.1% | 0.01% | 0.0% |
| Q4 2020 | $1,186,000 | -15.2% | 449,056 | +0.2% | 0.01% | -22.2% |
| Q3 2020 | $1,398,000 | -19.3% | 448,195 | +6.8% | 0.01% | -25.0% |
| Q2 2020 | $1,733,000 | +321.7% | 419,687 | +64.5% | 0.01% | +200.0% |
| Q1 2020 | $411,000 | -32.2% | 255,184 | +4.5% | 0.00% | 0.0% |
| Q4 2019 | $606,000 | +43.3% | 244,244 | -2.9% | 0.00% | +33.3% |
| Q3 2019 | $423,000 | -37.4% | 251,544 | -6.9% | 0.00% | -25.0% |
| Q2 2019 | $676,000 | -23.5% | 270,237 | -6.1% | 0.00% | -33.3% |
| Q1 2019 | $884,000 | +9.7% | 287,914 | -5.6% | 0.01% | +20.0% |
| Q4 2018 | $806,000 | -47.4% | 305,139 | -14.2% | 0.01% | -44.4% |
| Q3 2018 | $1,533,000 | +10.7% | 355,614 | +1.2% | 0.01% | +12.5% |
| Q2 2018 | $1,385,000 | +81.8% | 351,525 | -4.5% | 0.01% | +60.0% |
| Q1 2018 | $762,000 | -4.0% | 368,050 | -2.7% | 0.01% | 0.0% |
| Q4 2017 | $794,000 | -27.8% | 378,250 | -7.8% | 0.01% | -28.6% |
| Q3 2017 | $1,100,000 | +10.9% | 410,350 | -1.2% | 0.01% | 0.0% |
| Q2 2017 | $992,000 | +48.5% | 415,250 | +0.7% | 0.01% | +75.0% |
| Q1 2017 | $668,000 | +15.0% | 412,250 | +2.3% | 0.00% | 0.0% |
| Q4 2016 | $581,000 | -18.5% | 403,175 | -0.4% | 0.00% | -20.0% |
| Q3 2016 | $713,000 | +29.4% | 404,975 | 0.0% | 0.01% | +25.0% |
| Q2 2016 | $551,000 | +8.0% | 404,975 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $510,000 | -21.3% | 404,975 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $648,000 | +20.9% | 404,975 | +18.6% | 0.01% | +25.0% |
| Q3 2015 | $536,000 | +80.5% | 341,325 | +96.6% | 0.00% | +33.3% |
| Q2 2015 | $297,000 | +280.8% | 173,600 | +300.9% | 0.00% | +200.0% |
| Q1 2015 | $78,000 | +41.8% | 43,300 | +238.3% | 0.00% | – |
| Q4 2014 | $55,000 | – | 12,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |